Hemodynamic Monitoring System Market Report 2031 by Segments, Geography, Dynamics, Recent Developments, and Strategic Insights

Hemodynamic Monitoring System Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Noninvasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Invasive Hemodynamic Monitoring Systems), Product (Monitors and Disposables), End User (Hospitals, Home Care, Cath Labs, and Ambulatory Care Center), and Geography

  • Report Code : TIPHE100000982
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Hemodynamic Monitoring System Market Analysis by 2031

Buy Now

The hemodynamic monitoring system market size is projected to reach US$ 2.65 billion by 2031 from US$ 1.58 billion in 2023. The market is expected to register a CAGR of 6.7% during 2023–2031. Use of artificial intelligence and machine learning is likely to remain key trend in the market.

Hemodynamic Monitoring System Market Analysis

Hemodynamic monitoring system is used to monitor the blood circulation of patient and evaluate the heart health. Thus, increasing prevalence of heart related diseases due to growing geriatric population and detection of pediatric heart conditions is fueling the demand for hemodynamic monitoring system. In addition, increasing investment for research and development of hemodynamic monitoring system, awareness initiatives for heart health, and growing focus on patient safety and care quality is driving the growth of the hemodynamic monitoring system market. Moreover, rising demand for critical care monitoring in intensive care units, emergency departments, and operating rooms is also fueling the growth of the market. Expansion of home healthcare services and remote patient monitoring program acts as an opportunity for growth of the market in the forecast period.

Hemodynamic Monitoring System Market Overview

Geographically, Asia Pacific is expected to register highest CAGR in the forecast period 2023-2031. Increasing focus on market players on introduction of technologically advanced products in Asia Pacific, growing adoption of home healthcare services, growing demand for non-invasive diagnostic techniques, and increasing R&D activities is fueling the growth of the Asia Pacific hemodynamic monitoring system market. Moreover, growing geriatric population, rising healthcare expenditure, increasing prevalence of cardiovascular diseases (CVDS), and improving government support for creating awareness about heart health is fueling the growth of the market in Asia Pacific.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hemodynamic Monitoring System Market: Strategic Insights

Hemodynamic Monitoring System Market

  • CAGR (2023 - 2031)
    6.7%
  • Market Size 2023
    US$ 1.58 Billion
  • Market Size 2031
    US$ 2.65 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing prevalence of cardiovascular diseases is surging the demand for hemodynamic monitors
FUTURE TRENDS
  • Growth in geriatric population globally is expected to fuel the EEG devices market growth as they are prone to cardiovascular diseases and heart diseases
OPPORTUNITIES
  • Adoption of Remote Patient Monitoring acts as an opportunity for growth of the market

Key Players

  • Koninklijke Philips NV
  • Osypka Medical GmbH
  • General Electric Co
  • Edwards Lifesciences Corporation
  • Schwarzer Cardiotek
  • Getinge Group
  • Deltex Medical
  • ICU MEDICAL INC.
  • Masimo
  • Baxter International Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Type
  • Noninvasive Hemodynamic Monitoring Systems
  • Minimally Invasive Hemodynamic Monitoring Systems
  • Invasive Hemodynamic Monitoring Systems
Product
  • Monitors
  • Disposables
End User
  • Hospitals
  • Home Care
  • Cath Labs
  • Ambulatory Care Center
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Hemodynamic Monitoring System Market Drivers and Opportunities

Increasing Prevalence of Cardiovascular Diseases to Favor Market

Cardiovascular diseases (CVDs) cause millions of deaths every year worldwide. According to the 2022 heart disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, an estimated 119.1 million people died of CVDs in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. The major causes of CVDs are hypertension, obesity, and diabetes. As per the World Health Organization (WHO), ~17.9 million lives are lost due to CVD every year, i.e., ~32% of all deaths reported globally. The awareness regarding CPR is high in western countries. According to the Centers for Disease Control and Prevention (CDC), ~350,000 cases of out-of-hospital cardiac arrest (OHCA) occur in the US every year. Hemodynamic monitors allow measurement of cardiac functions and blood circulation in cardiac patients. The monitoring allows physicians to measure blood pressure from inside the veins, arteries, and heart. Thus, growing prevalence of CVDs is surging the demand for hemodynamic monitors.

Adoption of Remote Patient Monitoring act as an Opportunity for Market Growth

By monitoring a patient’s vitals remotely, healthcare professionals can avoid admissions to healthcare facilities. If the cases can be handled virtually, beds are reserved only for patients requiring critical care, which allows hospital administrations to manage their resources more effectively. A shift from long-term facilities, inpatient rehabilitation, and skilled nursing facilities to home care settings results in greater chances of better, consistent, and timely interaction between patient and doctor owing to the growing prominence of cloud and mobility-driven medical devices. Increasing adoption of remote patient monitoring by integrating devices with electronic medical records (EMR) for real-time analysis of the results creating opportunity for growth of the hemodynamic monitors.

Hemodynamic Monitoring System Market Report Segmentation Analysis

Key segments that contributed to the derivation of the hemodynamic monitoring system market analysis are product, type, and end user.

  • Based on type, the hemodynamic monitoring system market is divided into noninvasive hemodynamic monitoring system, minimally invasive hemodynamic monitoring systems, and invasive hemodynamic monitoring systems. The noninvasive hemodynamic monitoring system segment is further divided into non-Invasive cardiac system and others. The invasive hemodynamic monitoring system segment held the largest market share in 2023.
  • In terms of product, the market is bifurcated into monitors and disposables. The disposables segment held a significant share of the market in 2023.
  • Based on end user, the hemodynamic monitoring system market is divided into hospitals, cath labs, home care, and ambulatory surgical centers. The hospitals segment held the largest market share in 2023.

Hemodynamic Monitoring System Market Share Analysis by Geography

The geographic scope of the hemodynamic monitoring system market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market. The projected growth of the hemodynamic monitoring system market in North America is attributed to the factors such as increasing health expenditure, rising cardiovascular disease prevalence, increasing awareness about heart health, and growing geriatric population. The prevalence of CVDs in the US is much higher, as more than 50% population is suffering from different types of CVDs. According to the Centers for Disease Control and Prevention (CDC), every year, more than 0.6 million people die due to CVDs; this nearly accounts for one in every four deaths. The primary cause of CVDs among people is hypertension, obesity, and diabetes. Furthermore, various organizations are focusing on introducing programs for the care and treatment of CVDs and creating awareness about these treatments in Mexico. For instance, in June 2022, the American Heart Association launched a 2-year program funded by Novartis Mexico to improve the consistency of care for CVDs.

Hemodynamic Monitoring System Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.58 Billion
Market Size by 2031 US$ 2.65 Billion
Global CAGR (2023 - 2031) 6.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Noninvasive Hemodynamic Monitoring Systems
  • Minimally Invasive Hemodynamic Monitoring Systems
  • Invasive Hemodynamic Monitoring Systems
By Product
  • Monitors
  • Disposables
By End User
  • Hospitals
  • Home Care
  • Cath Labs
  • Ambulatory Care Center
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Koninklijke Philips NV
  • Osypka Medical GmbH
  • General Electric Co
  • Edwards Lifesciences Corporation
  • Schwarzer Cardiotek
  • Getinge Group
  • Deltex Medical
  • ICU MEDICAL INC.
  • Masimo
  • Baxter International Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Hemodynamic Monitoring System Market News and Recent Developments

    The Hemodynamic Monitoring System market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the hemodynamic monitoring system market are listed below:

    • Mindray Medical with Edwards Lifesciences integrated Edwards FloTrac sensor for hemodynamic monitoring into Mindray's flagship BeneVision N series patient monitors in the European market, following their launch in China in 2022. (Source: Mindray, Company Website, June 2023)
    • Royal Philips integrated its Interventional Hemodynamic System and market-leading portable Patient Monitor IntelliVue X3, providing advanced hemodynamic (blood flow) measurements at the tableside in the cath lab and continuous monitoring of key vital signs throughout the patient journey. (Source: Philips, Company Website, May 2021)

    Hemodynamic Monitoring System Market Report Coverage and Deliverables

    The “hemodynamic monitoring system Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • hemodynamic monitoring system market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • hemodynamic monitoring system market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • hemodynamic monitoring system market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the hemodynamic monitoring system market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Type, Product, and End User

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Frequently Asked Questions


    Which region dominated the hemodynamic monitoring system market in 2023?

    North America dominated the hemodynamic monitoring system market in 2023.

    What are the driving factors impacting the hemodynamic monitoring system market?

    Growing incidences of cardiovascular diseases, rising demand for critical care monitoring, and significantly rising elderly population are among the most influential factors responsible for the market growth.

    What are the future trends of the hemodynamic monitoring system market?

    Use of artificial intelligence and machine learning are likely to remain key trends in the hemodynamic monitoring system market.

    Which are the leading players operating in the hemodynamic monitoring system market?

    Koninklijke Philips NV, Osypka Medical GmbH, General Electric Co, Edwards Lifesciences Corporation, Schwarzer Cardiotek, Getinge Group, Deltex Medical, ICU MEDICAL INC., Masimo, and Baxter International Inc. are among the key players operating in the market.

    What would be the estimated value of the hemodynamic monitoring system market by 2031?

    The hemodynamic monitoring system market is estimated to reach US$ 2.65 billion in 2031.

    What is the expected CAGR of the hemodynamic monitoring system market?

    The hemodynamic monitoring system market is anticipated to record a CAGR of 6.7% during 2023–2031.

    Trends and growth analysis reports related to Medical Device : READ MORE..